Co-Diagnostics, Inc. (CODX) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 2 Buy, 3 Hold.
The consensus price target is $6.00, representing an upside of 334.8% from the current price $1.38.
Analysts estimate Earnings Per Share (EPS) of $-36.60 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.24 vs est $-36.60 (beat +96.6%). 2025: actual $-35.25 vs est $-21.00 (missed -67.9%). Analyst accuracy: 0%.
CODX Stock — 12-Month Price Forecast
$6.00
▲ +334.78% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Co-Diagnostics, Inc., the price target is $6.00.
The average price target represents a +334.78% change from the last price of $1.38.
CODX Analyst Ratings
Hold
Based on 5 analysts giving stock ratings to Co-Diagnostics, Inc. in the past 3 months
EPS Estimates — CODX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.24
vs Est –$36.60
▲ 2,851.6% off
2025
Actual –$35.25
vs Est –$21.00
▼ 40.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CODX
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.004B
▼ 5.8% off
2025
Actual $0.001B
vs Est $0.000B
▲ 22.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
